This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Aug 17;394(10198):560-561.

doi: 10.1016/S0140-6736(19)30699-3.

SGLT-2 inhibitors for people with type 2 diabetes - Authors' reply

Thomas A Zelniker¹, Stephen D Wiviott¹, Itamar Raz², Marc S Sabatine³

Affiliations

Affiliations

¹ TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
² The Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel.
³ TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA. Electronic address: msabatine@partners.org.

PMID: 31423992
DOI: 10.1016/S0140-6736(19)30699-3

Comment

SGLT-2 inhibitors for people with type 2 diabetes - Authors' reply

Thomas A Zelniker et al. Lancet. 2019.

. 2019 Aug 17;394(10198):560-561.

doi: 10.1016/S0140-6736(19)30699-3.

Authors

Thomas A Zelniker¹, Stephen D Wiviott¹, Itamar Raz², Marc S Sabatine³

Affiliations

¹ TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
² The Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel.
³ TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA. Electronic address: msabatine@partners.org.

PMID: 31423992
DOI: 10.1016/S0140-6736(19)30699-3

No abstract available

PubMed Disclaimer

Comment on

SGLT-2 inhibitors for people with type 2 diabetes.
Malaga G, Ruiz EF. Malaga G, et al. Lancet. 2019 Aug 17;394(10198):559-560. doi: 10.1016/S0140-6736(19)30720-2. Lancet. 2019. PMID: 31423990 No abstract available.
SGLT-2 inhibitors for people with type 2 diabetes.
Strandberg TE, Petrovic M, Benetos A. Strandberg TE, et al. Lancet. 2019 Aug 17;394(10198):560. doi: 10.1016/S0140-6736(19)30719-6. Lancet. 2019. PMID: 31423991 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information